š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
Background: \- Recent research has shown that causing an immune response t...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2010-12-01
Trial ID
NCT01258868
Treatments Being Tested
The purpose of this trial is to assess whether treatment with NY-ESO-1 ISCO...
Status
Completed
Location
Sydney Melanoma Unit - Royal Prince Alfred Hospital
Start Date
2005-09
Trial ID
NCT00199901
Treatments Being Tested
Background: \- A tumor cell vaccine is an experimental cancer treatment. C...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2011-04-18
Trial ID
NCT01341496
Treatments Being Tested
This study will determine whether at least one formulation of an experiment...
Status
Completed
Location
Multiple Locations
Start Date
2012-07-23
Trial ID
NCT01477580
Treatments Being Tested
This was a Phase 2, open-label study of the NY-ESO-1 ISCOMATRIXĀ® (ISCOM) va...
Status
Completed
Location
Peter MacCallum Cancer Institute
Start Date
2003-11-28
Trial ID
NCT00518206
Treatments Being Tested
The purpose of this study is to test the safety, tolerability and the immun...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00464334
Treatments Being Tested
Background: During recent years, cancer-testis (CT) antigens (CTA), partic...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-09-03
Trial ID
NCT02054104
Treatments Being Tested